Genesis Cancer and Blood Institute and American Oncology Network Welcome Dr. Tyler Fugere
American Oncology Network (NASDAQ:AONC) announced that Genesis Cancer and Blood Institute, its partner practice, has welcomed Dr. Tyler Fugere to its physician care team. Dr. Fugere, a Board-certified medical oncologist and hematologist, joins a team of experienced physicians at Genesis, which operates 11 locations across Arkansas.
Dr. Fugere earned her medical degree, completed her internal medicine residency, and hematology-oncology fellowship at the University of Arkansas for Medical Sciences. She began seeing patients at Genesis's Benton and Little Rock clinics on August 1, 2025. Genesis Cancer and Blood Institute offers comprehensive services including cancer diagnosis, treatment, clinical trials, survivorship, and patient support services.
American Oncology Network (NASDAQ:AONC) ha annunciato che Genesis Cancer and Blood Institute, suo partner, ha accolto nel suo team medico la Dott.ssa Tyler Fugere. La Dott.ssa Fugere, oncologa medica e ematologa certificata, si unisce a un gruppo di medici esperti di Genesis, che gestisce 11 sedi in Arkansas.
La Dott.ssa Fugere ha conseguito la laurea in medicina, completato la specializzazione in medicina interna e la borsa di studio in ematologia-oncologia presso l'Università di Arkansas per le Scienze Mediche. Ha iniziato a visitare i pazienti presso le cliniche di Benton e Little Rock di Genesis il 1° agosto 2025. Genesis Cancer and Blood Institute offre servizi completi che includono diagnosi e trattamento del cancro, sperimentazioni cliniche, supporto ai sopravvissuti e assistenza ai pazienti.
American Oncology Network (NASDAQ:AONC) anunció que Genesis Cancer and Blood Institute, su práctica asociada, ha incorporado a la Dra. Tyler Fugere a su equipo médico. La Dra. Fugere, oncóloga médica y hematóloga certificada, se une a un equipo de médicos experimentados en Genesis, que opera en 11 ubicaciones en Arkansas.
La Dra. Fugere obtuvo su título de médico, completó su residencia en medicina interna y su especialización en hematología-oncología en la Universidad de Arkansas para Ciencias Médicas. Comenzó a atender pacientes en las clínicas de Benton y Little Rock de Genesis el 1 de agosto de 2025. Genesis Cancer and Blood Institute ofrece servicios integrales que incluyen diagnóstico y tratamiento del cáncer, ensayos clínicos, atención a sobrevivientes y servicios de apoyo al paciente.
American Oncology Network (NASDAQ:AONC)는 파트너 기관인 Genesis Cancer and Blood Institute가 타일러 퓨제어 박사를 의료진에 영입했다고 발표했습니다. 퓨제어 박사는 전문의 자격을 갖춘 혈액종양내과 전문의로, 아칸소 주 전역에 11개 지점을 운영하는 Genesis의 숙련된 의료진 팀에 합류했습니다.
퓨제어 박사는 아칸소 의과대학에서 의학 학위를 받고 내과 전공의 과정과 혈액종양내과 펠로우십을 마쳤습니다. 2025년 8월 1일부터 Genesis의 벤튼 및 리틀록 클리닉에서 환자 진료를 시작했습니다. Genesis Cancer and Blood Institute는 암 진단, 치료, 임상 시험, 생존자 관리 및 환자 지원 서비스를 포함한 종합적인 의료 서비스를 제공합니다.
American Oncology Network (NASDAQ:AONC) a annoncé que Genesis Cancer and Blood Institute, son cabinet partenaire, a accueilli le Dr Tyler Fugere au sein de son équipe médicale. Le Dr Fugere, oncologue médical et hématologue certifié, rejoint une équipe de médecins expérimentés chez Genesis, qui opère dans 11 sites à travers l'Arkansas.
Le Dr Fugere a obtenu son diplôme de médecine, complété sa résidence en médecine interne et sa spécialisation en hématologie-oncologie à l'Université des sciences médicales de l'Arkansas. Elle a commencé à recevoir des patients dans les cliniques de Benton et Little Rock de Genesis le 1er août 2025. Genesis Cancer and Blood Institute propose des services complets, incluant le diagnostic et le traitement du cancer, les essais cliniques, le suivi des survivants et le soutien aux patients.
American Oncology Network (NASDAQ:AONC) gab bekannt, dass das Partnerzentrum Genesis Cancer and Blood Institute Dr. Tyler Fugere in sein Ärzteteam aufgenommen hat. Dr. Fugere, eine zertifizierte Fachärztin für medizinische Onkologie und Hämatologie, verstärkt das erfahrene Ärzteteam von Genesis, das 11 Standorte in Arkansas betreibt.
Dr. Fugere erhielt ihren medizinischen Abschluss, absolvierte ihre Facharztausbildung in Innerer Medizin sowie ihr Fellowship in Hämatologie-Onkologie an der University of Arkansas for Medical Sciences. Sie begann am 1. August 2025 mit der Patientenbetreuung in den Kliniken von Genesis in Benton und Little Rock. Das Genesis Cancer and Blood Institute bietet umfassende Leistungen wie Krebsdiagnose, Behandlung, klinische Studien, Nachsorge und Patientenunterstützung an.
- None.
- None.
Board-certified medical oncologist and hematologist joins physician team
HOT SPRINGS, Ark., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Genesis Cancer and Blood Institute, a partner practice of American Oncology Network (AON), is pleased to welcome Board-certified physician Tyler Fugere, MD, to its physician care team. She joins an experienced group of physicians including Drs. Brad Baltz, Jim Chen, Timothy Webb, Robert Muldoon, Stephen “Fred” Divers, Lynn Cleveland, Lingyi Chen, Sunil Kakadia, and Kristen Sager.
Dr. Fugere is a Board-certified medical oncologist and hematologist. She earned her medical degree from the University of Arkansas for Medical Sciences (UAMS) in Little Rock, where she also completed her internal medicine residency and hematology-oncology fellowship. Originally from Benton, Arkansas, she graduated summa cum laude from Benton High School and later earned her undergraduate degree from Ouachita Baptist University in Arkadelphia.
She is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the National Comprehensive Cancer Network. Dr. Fugere is passionate about providing personalized, patient-centered care in the community setting.
“I’m honored to join Genesis Cancer and Blood Institute,” said Dr. Fugere. “Genesis has a long-standing reputation for excellence in patient care, and its values align perfectly with my own. I look forward to being part of a team that puts patients first while offering the latest in evidence-based treatment.”
With 10 medical oncologists and five advance practice providers across 11 locations in Arkansas, Genesis Cancer and Blood Institute offers comprehensive services for cancer diagnosis, treatment, clinical trials, survivorship and patient support—all delivered close to home.
“We’re excited to welcome Dr. Fugere to the Genesis team,” said Dr. Timothy Webb, medical oncologist at Genesis. “Her knowledge, compassion and dedication to personalized care make her a perfect addition to our group. I know our patients will benefit from her expertise.”
“On behalf of AON, I’m pleased to welcome Dr. Fugere to Genesis and to our national network,” said Stephen “Fred” Divers, MD, medical oncologist at Genesis and AON’s chief medical officer. “Her commitment to delivering high-quality, community-based care reflects AON’s mission to make exceptional cancer treatment accessible to patients where they live. She will be an invaluable asset to both our team and the patients we serve.”
Dr. Fugure began seeing patients at the Genesis Benton and Little Rock clinics on Aug. 1, 2025.
For more information about AON, visit AONcology.com. To learn more about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.
About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About Genesis Cancer and Blood Institute
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. Brad Baltz, Dr. Jim Chen, Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, and Dr. Tyler Fugere. Learn more at genesiscancerblood.com.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ba6e1373-f12e-478d-b93d-f74024bbec31
Media Contact: Karen Riley Sawyer American Oncology Network Karen.Sawyer@AONcology.com
FAQ
Who is Dr. Tyler Fugere and when did she join Genesis Cancer and Blood Institute?
What services does Genesis Cancer and Blood Institute offer?
Where did Dr. Tyler Fugere complete her medical education?
At which Genesis Cancer and Blood Institute locations will Dr. Fugere practice?
How many medical oncologists does Genesis Cancer and Blood Institute have?
